Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents

NCT03206671 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.

NCT NCT03206671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03206671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
Lead sponsor
University Hospital Muenster
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 3, 2017
Completion date
June 30, 2027
Enrollment
650 (estimated)
Sites
88

Conditions

As the registry lists them; a condition with its own page is linked.

mature b-cell non-hodgkin lymphoma